More importantly, we showed that this basal pro-inflammatory status observed in CTEPH-ECs is, at least partially, regulated through NF-κB signaling, and blocking NF-κB activation might be an important target in CTEPH to prevent disease progression or recurrent PH. The gene discussed is NFKB1; the disease is chronic thromboembolic pulmonary hypertension.